<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Immunonutrition for acute respiratory distress syndrome (ARDS) in adults - Dushianthan, A - 2019 | Cochrane Library</title> <meta content="Immunonutrition for acute respiratory distress syndrome (ARDS) in adults - Dushianthan, A - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012041.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Immunonutrition for acute respiratory distress syndrome (ARDS) in adults - Dushianthan, A - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012041.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012041.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Immunonutrition for acute respiratory distress syndrome (ARDS) in adults" name="citation_title"/> <meta content="Ahilanandan Dushianthan" name="citation_author"/> <meta content="University Hospital Southampton NHS Foundation Trust" name="citation_author_institution"/> <meta content="adushianthan@gmail.com" name="citation_author_email"/> <meta content="Rebecca Cusack" name="citation_author"/> <meta content="University of Southampton" name="citation_author_institution"/> <meta content="Victoria A Burgess" name="citation_author"/> <meta content="University Hospital Southampton NHS Foundation Trust" name="citation_author_institution"/> <meta content="Michael PW Grocott" name="citation_author"/> <meta content="Faculty of Medicine, University of Southampton" name="citation_author_institution"/> <meta content="Philip C Calder" name="citation_author"/> <meta content="University of Southampton" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD012041.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/01/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012041.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012041.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012041.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Antioxidants [*administration &amp; dosage, adverse effects]; Cause of Death; Docosahexaenoic Acids [administration &amp; dosage]; Eicosapentaenoic Acid [administration &amp; dosage]; Enteral Nutrition [adverse effects, *methods]; Fatty Acids, Omega‐3 [*administration &amp; dosage, adverse effects]; Intensive Care Units [statistics &amp; numerical data]; Length of Stay; Oxygen Inhalation Therapy [statistics &amp; numerical data]; Randomized Controlled Trials as Topic; Respiration, Artificial [statistics &amp; numerical data]; Respiratory Distress Syndrome [mortality, *therapy]; gamma‐Linolenic Acid [administration &amp; dosage]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012041.pub2&amp;doi=10.1002/14651858.CD012041.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="UiM8QuvV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012041\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012041\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANS","ru","ms","ja","pl","fr","zh_HANT","hr","fa","th"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012041.pub2",title:"Immunonutrition for acute respiratory distress syndrome (ARDS) in adults",firstPublishedDate:"Jan 24, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Emergency and Critical Care Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012041.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012041.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012041.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012041.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012041.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012041.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012041.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012041.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012041.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012041.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>9493 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012041.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-sec-0102"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-sec-0060"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-sec-0096"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/appendices#CD012041-sec-0107"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/table_n/CD012041StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/table_n/CD012041StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Immunonutrition for acute respiratory distress syndrome (ARDS) in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#CD012041-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Ahilanandan Dushianthan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#CD012041-cr-0003">Rebecca Cusack</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#CD012041-cr-0004">Victoria A Burgess</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#CD012041-cr-0005">Michael PW Grocott</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information#CD012041-cr-0006">Philip C Calder</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information/en#CD012041-sec-0114">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 January 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012041.pub2">https://doi.org/10.1002/14651858.CD012041.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012041-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012041-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012041-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012041-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012041-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD012041-abs-0018">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012041-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012041-abs-0001" lang="en"> <section id="CD012041-sec-0001"> <h3 class="title" id="CD012041-sec-0001">Background</h3> <p>Acute respiratory distress syndrome (ARDS) is an overwhelming systemic inflammatory process associated with significant morbidity and mortality. Pharmacotherapies that moderate inflammation in ARDS are lacking. Several trials have evaluated the effects of pharmaconutrients, given as part of a feeding formula or as a nutritional supplement, on clinical outcomes in critical illness and ARDS. </p> </section> <section id="CD012041-sec-0002"> <h3 class="title" id="CD012041-sec-0002">Objectives</h3> <p>To systematically review and critically appraise available evidence on the effects of immunonutrition compared to standard non‐immunonutrition formula feeding on mechanically ventilated adults (aged 18 years or older) with acute respiratory distress syndrome (ARDS). </p> </section> <section id="CD012041-sec-0003"> <h3 class="title" id="CD012041-sec-0003">Search methods</h3> <p>We searched MEDLINE, Embase, CENTRAL, conference proceedings, and trial registries for appropriate studies up to 25 April 2018. We checked the references from published studies and reviews on this topic for potentially eligible studies. </p> </section> <section id="CD012041-sec-0004"> <h3 class="title" id="CD012041-sec-0004">Selection criteria</h3> <p>We included all randomized controlled trials (RCTs) and quasi‐randomized controlled trials comparing immunonutrition versus a control or placebo nutritional formula in adults (aged 18 years or older) with ARDS, as defined by the Berlin definition of ARDS or, for older studies, by the American‐European Consensus Criteria for both ARDS and acute lung injury. </p> </section> <section id="CD012041-sec-0005"> <h3 class="title" id="CD012041-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed the quality of studies and extracted data from the included trials. We sought additional information from study authors. We performed statistical analysis according to Cochrane methodological standards. Our primary outcome was all‐cause mortality. Secondary outcomes included intensive care unit (ICU) length of stay, ventilator days, indices of oxygenation, cardiac adverse events, gastrointestinal adverse events, and total number of adverse events. We used GRADE to assess the quality of evidence for each outcome. </p> </section> <section id="CD012041-sec-0006"> <h3 class="title" id="CD012041-sec-0006">Main results</h3> <p>We identified 10 randomized controlled trials with 1015 participants. All studies compared an enteral formula or additional supplemental omega‐3 fatty acids (i.e. eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA)), gamma‐linolenic acid (GLA), and antioxidants. We assessed some of the included studies as having high risk of bias due to methodological shortcomings. Studies were heterogenous in nature and varied in several ways, including type and duration of interventions given, calorific targets, and reported outcomes. All studies reported mortality. For the primary outcome, study authors reported no differences in all‐cause mortality (longest period reported) with the use of an immunonutrition enteral formula or additional supplements of omega‐3 fatty acids and antioxidants (risk ratio (RR) 0.79, 95% confidence interval (CI) 0.59 to 1.07; participants = 1015; studies = 10; low‐quality evidence). </p> <p>For secondary outcomes, we are uncertain whether immunonutrition with omega‐3 fatty acids and antioxidants reduces ICU length of stay (mean difference (MD) ‐3.09 days. 95% CI ‐5.19 to ‐0.99; participants = 639; studies = 8; very low‐quality evidence) and ventilator days (MD ‐2.24 days, 95% CI ‐3.77 to ‐0.71; participants = 581; studies = 7; very low‐quality evidence). We are also uncertain whether omega‐3 fatty acids and antioxidants improve oxygenation, defined as ratio of partial pressure of arterial oxygen (PaO₂) to fraction of inspired oxygen (FiO₂), at day 4 (MD 39 mmHg, 95% CI 10.75 to 67.02; participants = 676; studies = 8), or whether they increase adverse events such as cardiac events (RR 0.87, 95% CI 0.09 to 8.46; participants = 339; studies = 3; very low‐quality evidence), gastrointestinal events (RR 1.11, 95% CI 0.71 to 1.75; participants = 427; studies = 4; very low‐quality evidence), or total adverse events (RR 0.91, 95% CI 0.67 to 1.23; participants = 517; studies = 5; very low‐quality evidence). </p> </section> <section id="CD012041-sec-0007"> <h3 class="title" id="CD012041-sec-0007">Authors' conclusions</h3> <p>This meta‐analysis of 10 studies of varying quality examined effects of omega‐3 fatty acids and/or antioxidants in adults with ARDS. This intervention may produce little or no difference in all‐cause mortality between groups. We are uncertain whether immunonutrition with omega‐3 fatty acids and antioxidants improves the duration of ventilator days and ICU length of stay or oxygenation at day 4 due to the very low quality of evidence. Adverse events associated with immunonutrition are also uncertain, as confidence intervals include the potential for increased cardiac, gastrointestinal, and total adverse events. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012041-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012041-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012041-abs-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012041-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012041-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012041-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD012041-abs-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012041-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012041-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012041-abs-0011">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012041-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD012041-abs-0019">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012041-abs-0007">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD012041-abs-0014">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012041-abs-0005" lang="en"> <h3>Immunonutrition for acute respiratory distress syndrome (ARDS) in adults</h3> <p><b>Background</b> </p> <p>Acute respiratory distress syndrome (ARDS) is a life‐threatening condition wherein the lungs are inflamed (irritated) and damaged. In this state, the lungs cannot deliver into the blood enough oxygen for the body’s vital organs. It is usually seen in patients who are already seriously ill. Currently, no specific effective therapeutic options are available for this condition. Alternatively, change in dietary intake has been deployed. Modification of the nutrition given to adults with ARDS, to include components of food that have an anti‐inflammatory effect, could reduce lung inflammation and improve outcomes in adults with this condition. Omega‐3 fatty acids (known as DHA and EPA) are found in fish oils and can have an anti‐inflammatory effect. Reviewers examined reported outcomes and effects of changes in nutrition among studies involving adults with ARDS. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current up to April 2018. We included in this review 10 studies with 1015 adult participants. These studies were conducted in intensive care units and compared standard nutrition (the usual nutrition given to patients with ARDS) versus nutrition supplemented with omega‐3 fatty acids or placebo (a substance with no active effect), and compared either with or without antioxidants. Antioxidants are molecules that can inhibit or slow down oxidation ‐ a reaction that can cause inflammation and damage cells. </p> <p><b>Key results</b> </p> <p>It is unclear whether use of omega‐3 fatty acids and antioxidants as part of nutritional intake in patients with ARDS improves long‐term survival. It is uncertain whether omega‐3 fatty acids and antioxidants reduce length of ICU stay and the number of days spent on a ventilator, or if they improve oxygenation. It is also unclear if this type of nutrition causes increased harm. </p> <p><b>Quality of evidence</b> </p> <p>Findings of this review are limited by lack of standardization among the included studies in terms of methods, types of nutritional supplements given, and reporting of outcome measures. We rated the quality of evidence as low to very low. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012041-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012041-sec-0102"></div> <h3 class="title" id="CD012041-sec-0103">Implications for practice</h3> <section id="CD012041-sec-0103"> <p>This meta‐analysis evaluated 10 heterogenous studies of varying quality and analysed effects of omega‐3 fatty acids and/or antioxidants in critically ill adults with ARDS. We were not able to find clinical trials of any other immunonutrition intervention provided to this patient group. Despite inclusion of all studies in our meta‐analysis, we were not able to pool all studies for every anticipated clinical outcome due to lack of standardized outcome reporting. This may have introduced bias into our analysis. Our results suggest that no mortality benefit is derived from the use of omega‐3 fatty acids and/or antioxidants in ARDS. Uncertain evidence suggests reductions in duration of mechanical ventilation and ICU length of stay, along with improved oxygenation. The quality of evidence was very low due to several factors, including poor quality small trials with high risk of bias, clinical and methodological heterogeneity, and issues due to imprecision and inconsistency between trials, with additional indirectness due to an imbalance in nutrition provided to the comparator groups. </p> </section> <h3 class="title" id="CD012041-sec-0104">Implications for research</h3> <section id="CD012041-sec-0104"> <p>Research shows no mortality benefit associated with use of immunonutrition in ARDS populations. Current data do not justify a large randomized controlled trial on this topic but would support targeted proof‐of‐concept studies in particular groups of patients to refine the intervention. Consistent reporting of outcome measures by researchers will be important to allow combinations of results in subsequent meta‐analyses. Mortality is unlikely to be the best outcome measure for such studies. Cost‐effectiveness data are notably absent from current studies and should be collected in the future. The most promising areas for future evaluation include continuous supplementation with a balanced formula for both control and intervention groups with additional supplementation for the intervention group. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012041-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012041-sec-0029"></div> <div class="table" id="CD012041-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Omega‐3 fatty acids and antioxidants compared with placebo or standard nutrition for acute respiratory distress syndrome (ARDS)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Omega‐3 fatty acids and antioxidants compared with placebo or standard nutrition for acute respiratory distress syndrome (ARDS)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older studies, the American‐European Consensus Criteria for both ARDS and acute lung injury </p> <p><b>Settings:</b> intensive care units in USA, Brazil, India, Iran, Israel, Japan, and Spain </p> <p><b>Intervention:</b> omega‐3 fatty acids and antioxidants </p> <p><b>Comparison:</b> placebo or standard nutrition </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or standard nutrition</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with omega‐3 fatty acids and antioxidants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> <p>(longest period reported)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>280 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>221 per 1000<br/> (165 to 299) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.79</p> <p>(0.59 to 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1015</p> <p>(10 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU LOS</p> <p>(days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean 18.09 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.09 days lower</p> <p>(5.19 lower to 0.99 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>639</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ventilator days</p> <p>(days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean 12.95 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.24 days lower</p> <p>(3.77 days lower to 0.71 days lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>581</p> <p>(7 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Indices of oxygenation</p> <p>(measured as PaO₂/FiO₂ ratio at day 4)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean 180.10 mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 39 mmHg higher</p> <p>(10.75 mmHg higher to 67.02 mmHg higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>659</p> <p>(7 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiac adverse events</p> <p>(study author reported anytime during study period)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/> (4 to 342) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.87</p> <p>(0.09 to 8.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>339</p> <p>(3 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal adverse events</p> <p>(study author reported anytime during study period)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>138 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>153 per 1000<br/> (98 to 241) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.11</p> <p>(0.71 to 1.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>427</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total number of adverse events</p> <p>(study author reported anytime during study period)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>243 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>222 per 1000</p> <p>(163 to 299)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.91</p> <p>(0.67 to 1.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>517</p> <p>(5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> ARDS: acute respiratory distress syndrome; CI: confidence interval; FiO₂: fraction of inspired oxygen; ICU: intensive care unit; LOS: length of stay; MD: mean difference; PaO₂: partial pressure of arterial oxygen; RCT: randomized controlled trial; RR: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias downgraded (‐1) due to selection, performance, and attrition bias in the included studies. </p> <p><sup>b</sup>Inconsistency downgraded (‐1) due to both clinical and methodological inconsistency in the included studies. </p> <p><sup>c</sup>Indirectness downgraded (‐1) due to indirect intervention and comparator in the included studies. In some included studies, control participants' nutritional formula may have increased the risk of harm. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012041-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012041-sec-0030"></div> <section id="CD012041-sec-0031"> <h3 class="title" id="CD012041-sec-0031">Description of the condition</h3> <p>Acute respiratory distress syndrome (ARDS) is characterized by severe hypoxic respiratory failure with significant global inflammatory processes and multi‐organ dysfunction. In the lung, diffuse epithelial and endothelial injury leads to increased alveolar capillary permeability and florid pulmonary oedema. Clinically, patients present with acute severe hypoxaemia and poor lung compliance, often necessitating invasive mechanical ventilation (<a href="./references#CD012041-bbs2-0018" title="DushianthanA , GrocottMP , PostleAD , CusackR . Acute respiratory distress syndrome and acute lung injury. Postgraduate Medical Journal2011;87(1031):612‐22. [PUBMED: 21642654] ">Dushianthan 2011</a>). The reported incidence of ARDS varies between countries and ranges from 16 to 78 per 100,000 population (<a href="./references#CD012041-bbs2-0049" title="WalkeyAJ , SummerR , HoV , AlkanaP . Acute respiratory distress syndrome: epidemiology and management approaches. Clinical Epidemiology2012;4:159‐69. [PUBMED: 22866017] ">Walkey 2012</a>). Several predisposing conditions and risk factors contribute to the development of ARDS. Shock, sepsis, pneumonia, aspiration, and pancreatitis are the clinical conditions commonly associated with increased likelihood of developing ARDS (<a href="./references#CD012041-bbs2-0020" title="GajicO , DabbaghO , ParkPK , AdesanyaA , ChangSY , HouP , et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. American Journal of Respiratory and Critical Care Medicine2011;183(4):462‐70. [PUBMED: 20802164] ">Gajic 2011</a>). Hospital mortality associated with ARDS varies between 27% and 45%, depending on the severity of the disease (<a href="./references#CD012041-bbs2-0043" title="ARDS Definition Task Force, RanieriVM , RubenfeldGD , ThompsonBT , FergusonND , CaldwellE , FanE , et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA2012;307(23):2526‐33. [PUBMED: 22797452] ">Ranieri 2012</a>). Survivors of ARDS have significant long‐term physical, cognitive, and psychological sequelae (<a href="./references#CD012041-bbs2-0024" title="HerridgeMS , TanseyCM , MattéA , TomlinsonG , Diaz‐GranadosN , CooperA , et al. Functional disability 5 years after acute respiratory distress syndrome. New England Journal of Medicine2011;364(14):1293‐304. [PUBMED: 21470008] ">Herridge 2011</a>; <a href="./references#CD012041-bbs2-0050" title="WangCY , CalfeeCS , PaulDW , JanzDR , MayAK , ZhuoH , et al. One‐year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensive Care Medicine2014;40(3):388‐96. [PUBMED: 24435201] ">Wang 2014</a>). </p> <p>Since the first description of ARDS in 1967 (<a href="./references#CD012041-bbs2-0012" title="AshbaughDG , BigelowDB , PettyTL , LevineBE . Acute respiratory distress in adults. Lancet1967;2(7511):319‐23. [PUBMED: 4143721] ">Ashbaugh 1967</a>), diagnostic definitions have evolved. The American‐European Consensus Criteria, published in 1994, provide the most frequently utilized definition among published randomized controlled trials (RCTs) of patients with ARDS (<a href="./references#CD012041-bbs2-0014" title="BernardGR , ArtigasA , BrighamKL , CarletJ , FalkeK , HudsonL , et al. The American‐European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine1994;149:818‐24. [PUBMED: 7509706] ">Bernard 1994</a>). According to these criteria, ARDS is recognized by bilateral pulmonary infiltrates on chest radiograph, with a ratio of partial pressure of oxygen (PaO₂)‐to‐fraction of inspired oxygen (FiO₂) of less than 200 mmHg, in the absence of raised left atrial hypertension. If less hypoxia is evident, defined as a PaO₂/FiO₂ ratio less than 300 mmHg, the syndrome is termed 'acute lung injury' (<a href="./references#CD012041-bbs2-0014" title="BernardGR , ArtigasA , BrighamKL , CarletJ , FalkeK , HudsonL , et al. The American‐European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine1994;149:818‐24. [PUBMED: 7509706] ">Bernard 1994</a>). However, due to several limitations of this definition, new criteria proposed by an expert consensus panel in 2012 constitute the 'Berlin definition' of ARDS (<a href="./references#CD012041-bbs2-0043" title="ARDS Definition Task Force, RanieriVM , RubenfeldGD , ThompsonBT , FergusonND , CaldwellE , FanE , et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA2012;307(23):2526‐33. [PUBMED: 22797452] ">Ranieri 2012</a>). This definition eliminated the existing term 'acute lung injury' and identified patients as having ARDS when they fulfilled all of the following criteria. </p> <p> <ol id="CD012041-list-0001"> <li> <p>Onset within seven days of a known clinical insult.</p> </li> <li> <p>Bilateral opacities on chest imaging.</p> </li> <li> <p>PaO₂/FiO₂ ratio less than 300 mmHg.</p> </li> <li> <p>Hypoxaemia not fully explained by cardiac failure or fluid overload.</p> </li> </ol> </p> <p>ARDS has been further subcategorized into mild (PaO₂/FiO₂ 201 to 300 mmHg), moderate (PaO₂/FiO₂ 100 to 200 mmHg), and severe (PaO₂/FiO₂ &lt; 100 mmHg), according to the severity of hypoxaemia (<a href="./references#CD012041-bbs2-0043" title="ARDS Definition Task Force, RanieriVM , RubenfeldGD , ThompsonBT , FergusonND , CaldwellE , FanE , et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA2012;307(23):2526‐33. [PUBMED: 22797452] ">Ranieri 2012</a>). </p> <p>At present, no effective pharmacotherapies are known to moderate the disease process of ARDS. Evidence suggests survival benefit from 'protective' lung ventilation strategies designed to minimize further lung injury during mechanical ventilation. </p> </section> <section id="CD012041-sec-0032"> <h3 class="title" id="CD012041-sec-0032">Description of the intervention</h3> <p>'Immunonutrition' refers to modulation of the immune system provided by specific interventions that modify dietary nutrients (<a href="./references#CD012041-bbs2-0015" title="CalderPC . Immunonutrition. BMJ2003;327(7407):117‐8. [PUBMED: 12869428] ">Calder 2003</a>). It has long been recognized that supplementary immunonutrients may alter the course of critical illness following sepsis, trauma, or surgery (<a href="./references#CD012041-bbs2-0013" title="BealeRJ , BrygDJ , BihariDJ . Immunonutrition in the critically ill: a systematic review of clinical outcome. Critical Care Medicine1999;27(12):2799‐805. [PUBMED: 10628629] ">Beale 1999</a>). Several specialized enteral and parenteral formulas with immunonutrients are currently available on the market. These primarily consist of a combination of antioxidant vitamins (vitamin C, vitamin E, beta‐carotene), trace elements (selenium, zinc), essential amino acids (glutamine, arginine) or essential fatty acids, such as omega‐3 fatty acids (eicosapentaenoic acid, docosahexaenoic acid), and gamma‐linolenic acid (GLA) (<a href="./references#CD012041-bbs2-0037" title="MizockBA . Immunonutrition and critical illness: an update. Nutrition2010;26:701‐7. [PUBMED: 20381315 ] ">Mizock 2010</a>). </p> </section> <section id="CD012041-sec-0033"> <h3 class="title" id="CD012041-sec-0033">How the intervention might work</h3> <p>Acute respiratory distress syndrome is characterized by overt recruitment of neutrophils, significant release of pro‐inflammatory cytokines and chemokines, and activation of pro‐coagulant cascades and prostaglandin pathways with increased oxidative stress, causing damage to both lipids and proteins (<a href="./references#CD012041-bbs2-0034" title="MatthayMA , ZemansRL . The acute respiratory distress syndrome: pathogenesis and treatment. Annual Review of Pathology2011;6:147‐63. [PUBMED: 20936936] ">Matthay 2011</a>). In patients with ARDS, significant imbalance in the antioxidant system with a relative increase in oxidative stress leads to increased alveolar injury (<a href="./references#CD012041-bbs2-0030" title="LangJD , McArdlePJ , O'ReillyPJ , MatalonS . Oxidant‐antioxidant balance in acute lung injury. Chest2002;122(Suppl 6):314S‐20S. [PUBMED: 12475808] ">Lang 2002</a>; <a href="./references#CD012041-bbs2-0036" title="MetnitzPG , BartensC , FischerM , FridrichP , SteltzerH , DrumlW . Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Medicine1999;25(2):180‐5. [PUBMED: 10193545] ">Metnitz 1999</a>; <a href="./references#CD012041-bbs2-0046" title="SchmidtR , LuboeinskiT , MarkartP , RuppertC , DaumC , GrimmingerF , et al. Alveolar antioxidant status in patients with acute respiratory distress syndrome. European Respiratory Journal2004;24(6):994‐9. [PUBMED: 15572544] ">Schmidt 2004</a>). Among critically ill patients in general, supplementation of antioxidants is associated with a favourable outcome (<a href="./references#CD012041-bbs2-0026" title="HeylandDK , DhaliwalR , SuchnerU , BergerMM . Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Medicine2005;31(3):327‐37. [PUBMED: 15605227] ">Heyland 2005</a>). Macronutrients such as glutamine and arginine also have immunomodulatory properties and have been used in several clinical trials of critically ill and surgical patients (<a href="./references#CD012041-bbs2-0011" title="AndrewsPJ , AvenellA , NobleDW , CampbellMK , CroalBL , SimpsonWG , et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ2011;342:d1542. [PUBMED: 21415104] ">Andrews 2011</a>; <a href="./references#CD012041-bbs2-0025" title="HeylandDK , NovakF , DroverJW , JainM , SuX , SuchnerU . Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA2001;286(8):944‐53. [PUBMED: 11509059] ">Heyland 2001</a>; <a href="./references#CD012041-bbs2-0027" title="HeylandDK , MuscedereJ , WischmeyerPE , CookD , JonesG , AlbertM , et al. A randomized trial of glutamine and antioxidants in critically ill patients. New England Journal of Medicine2013;368(16):1489‐97. [PUBMED: 23594003] ">Heyland 2013</a>; <a href="./references#CD012041-bbs2-0040" title="NovakF , HeylandDK , AvenellA , DroverJW , SuX . Glutamine supplementation in serious illness: a systematic review of the evidence. Critical Care Medicine2002;30(9):2022‐9. [MEDLINE: 12352035] ">Novak 2002</a>). Glutamine improves gut barrier function and can be an energy source for lymphocytes, neutrophils, and macrophages (<a href="./references#CD012041-bbs2-0039" title="NewsholmeEA , CrabtreeB , ArdawiMS . Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance. Quarterly Journal of Experimental Physiology1985;70(4):473‐89. [PUBMED: 3909197] ">Newsholme 1985</a>; <a href="./references#CD012041-bbs2-0047" title="SoaresAD , CostaKA , WannerSP , SantosRG , FernandesSO , MartinsFS , et al. Dietary glutamine prevents the loss of intestinal barrier function and attenuates the increase in core body temperature induced by acute heat exposure. British Journal of Nutrition2014;112(10):1601‐10. [PUBMED: 25322775] ">Soares 2014</a>), whereas arginine deficiency, which is commonly encountered following critical illness, may impair T‐cell function (<a href="./references#CD012041-bbs2-0042" title="PopovicPJ , ZehHJ3rd , OchoaJB . Arginine and immunity. Journal of Nutrition2007;137(6 Suppl 2):1681S‐6S. [PUBMED: 17513447] ">Popovic 2007</a>). Omega‐3 fatty acids are essential lipids, enriched in fish oil and consisting of polyunsaturated fatty acids such as eicosapentaenoic acid (EPA), alpha‐linolenic acid (ALA), and docosahexaenoic acid (DHA). Therapeutic supplementation of these nutrients, which have immunomodulatory properties, has been shown to moderate the inflammatory response through suppression of pro‐inflammatory eicosanoid biosynthesis (<a href="./references#CD012041-bbs2-0016" title="CalderPC . Immunonutrition in surgical and critically ill patients. British Journal of Nutrition2007;98(Suppl 1):S133‐9. [PUBMED: 17922951] ">Calder 2007</a>), attenuation of pulmonary neutrophil accumulation (<a href="./references#CD012041-bbs2-0032" title="MancusoP , WhelanJ , DeMicheleSJ , SniderCC , GuszczaJA , KarlstadMD . Dietary fish oil and fish and borage oil suppress intrapulmonary proinflammatory eicosanoid biosynthesis and attenuate pulmonary neutrophil accumulation in endotoxic rats. Critical Care Medicine1997;25(7):1198‐206. [PUBMED: 9233748] ">Mancuso 1997a</a>), reduction in lung permeability (<a href="./references#CD012041-bbs2-0033" title="MancusoP , WhelanJ , DeMicheleSJ , SniderCC , GuszczaJA , ClaycombeKJ , et al. Effects of eicosapentaenoic and gamma‐linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Critical Care Medicine1997;25(3):523‐32. [PUBMED: 9118672] ">Mancuso 1997b</a>), and attenuation of cardiopulmonary dysfunction in animal models of lung injury (<a href="./references#CD012041-bbs2-0038" title="MurrayMJ , KumarM , GregoryTJ , BanksPL , TazelaarHD , DeMicheleSJ . Select dietary fatty acids attenuate cardiopulmonary dysfunction during acute lung injury in pigs. American Journal of Physiology1995;269(6 Pt 2):H2090‐9. [PUBMED: 8594921] ">Murray 1995</a>). Furthermore, in endotoxaemic rat models, EPA has been shown to reduce pulmonary oedema (<a href="./references#CD012041-bbs2-0045" title="SaneS , BabaM , KusanoC , ShiraoK , AndohT , KamadaT , et al. Eicosapentaenoic acid reduces pulmonary edema in endotoxemic rats. Journal of Surgical Research2000;93(1):21‐7. [PUBMED: 10945939] ">Sane 2000</a>). </p> </section> <section id="CD012041-sec-0034"> <h3 class="title" id="CD012041-sec-0034">Why it is important to do this review</h3> <p>Various types of immunonutrition have the potential to influence clinical outcomes in critically ill patients (<a href="./references#CD012041-bbs2-0037" title="MizockBA . Immunonutrition and critical illness: an update. Nutrition2010;26:701‐7. [PUBMED: 20381315 ] ">Mizock 2010</a>). Several RCTs have investigated enteral supplementation of omega‐3 fatty acids and antioxidants, which, when combined in a meta‐analysis, showed a significant reduction in mortality with improvement in oxygenation for patients with acute lung injury (ALI) and ARDS (<a href="./references#CD012041-bbs2-0041" title="Pontes‐ArrudaA , DemicheleS , SethA , SingerP . The use of an inflammation‐modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta‐analysis of outcome data. Journal of Parenteral and Enteral Nutrition2008;32(6):596‐605. [PUBMED: 18974237] ">Pontes‐Arruda 2008</a>). However, recent studies have presented conflicting results, suggesting lack of benefit and possibly even harm caused by this intervention (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Among critically ill patients, enteral supplementation of glutamine conferred no clinical benefit (<a href="./references#CD012041-bbs2-0048" title="vanZantenAR , DhaliwalR , GarrelD , HeylandDK . Enteral glutamine supplementation in critically ill patients: a systematic review and meta‐analysis. Critical Care2015;19:294. [PUBMED: 26283217] ">van Zanten 2015</a>), and a large RCT showed a trend towards increased mortality associated with glutamine therapy (<a href="./references#CD012041-bbs2-0027" title="HeylandDK , MuscedereJ , WischmeyerPE , CookD , JonesG , AlbertM , et al. A randomized trial of glutamine and antioxidants in critically ill patients. New England Journal of Medicine2013;368(16):1489‐97. [PUBMED: 23594003] ">Heyland 2013</a>). This lack of demonstrable clinical benefit in recent studies conflicts with the established literature and may be due to heterogeneity of diseases within the population of critical care patients, or variations in the type, route, and dose of immunonutrients administered. Uncertainty arising from these conflicting results remains. This review aims to provide a comprehensive evaluation of the effects of immunonutrients for patients with ARDS. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012041-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012041-sec-0035"></div> <p>To systematically review and critically appraise available evidence on the effects of immunonutrition compared to standard non‐immunonutrition formula feeding on mechanically ventilated adults (aged 18 years or older) with acute respiratory distress syndrome (ARDS). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012041-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012041-sec-0036"></div> <section id="CD012041-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012041-sec-0038"> <h4 class="title">Types of studies</h4> <p>We included all randomized and quasi‐randomized controlled trials (qRCTs), with or without blinding. We did not apply language restrictions. We excluded non‐randomized controlled trials and observational studies due to increased risk of bias. </p> </section> <section id="CD012041-sec-0039"> <h4 class="title">Types of participants</h4> <p>We included all studies involving mechanically ventilated adult participants (aged 18 years or older) with ARDS as defined by the Berlin definition of ARDS (<a href="./references#CD012041-bbs2-0043" title="ARDS Definition Task Force, RanieriVM , RubenfeldGD , ThompsonBT , FergusonND , CaldwellE , FanE , et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA2012;307(23):2526‐33. [PUBMED: 22797452] ">Ranieri 2012</a>), or, for older studies, as defined by American‐European Consensus Criteria for both ARDS and ALI (<a href="./references#CD012041-bbs2-0014" title="BernardGR , ArtigasA , BrighamKL , CarletJ , FalkeK , HudsonL , et al. The American‐European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. American Journal of Respiratory and Critical Care Medicine1994;149:818‐24. [PUBMED: 7509706] ">Bernard 1994</a>). We restricted this review to trials conducted in critically ill adults, as pathophysiology and management strategies differ in paediatric and neonatal populations compared with adults. </p> </section> <section id="CD012041-sec-0040"> <h4 class="title">Types of interventions</h4> <p>Eligible trials included intervention groups consisting of participants given enteral or parenteral immunonutrients, additionally supplemented with or as part of a nutritional formula. In comparison, control groups comprised participants who received placebo or standard nutrition with a non‐immunonutrient formula feed. The immunonutrients could be amino acids (glutamine, arginine), antioxidants, or essential fatty acids, such as omega‐3 fatty acids supplemented for any duration and at any dose. </p> </section> <section id="CD012041-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD012041-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD012041-list-0002"> <li> <p>All‐cause mortality (longest period reported)</p> </li> </ol> </p> </section> <section id="CD012041-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD012041-list-0003"> <li> <p>28‐day mortality</p> </li> <li> <p>Intensive care unit (ICU) length of stay (LOS) and ICU‐free days at day 28 (days)</p> </li> <li> <p>Ventilator days and ventilator‐free days at day 28 (days)</p> </li> <li> <p>Hospital LOS (days)</p> </li> <li> <p>Indices of oxygenation (measured as PaO₂/FiO₂ ratio (mmHg) at days 4 and 7)</p> </li> <li> <p>Other organ failure (measured as change in organ failure scores: Sequential Organ Failure Assessment (SOFA) score, Multiple Organ Dysfunction Score (MODS); number of patients with new organ failure developed during the study period) </p> </li> <li> <p>Nosocomial infection (additional infection developed during hospital stay and reported anytime during the study period) </p> </li> <li> <p>Adverse events (author‐defined cardiac events, gastrointestinal events, and total adverse events reported anytime during the study period) </p> </li> </ol> </p> </section> </section> </section> <section id="CD012041-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012041-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We identified RCTs through literature searching with systematic and sensitive search strategies, as outlined in Chapter 6.4 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012041-bbs2-0028" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We did not apply restrictions to language or publication status. We searched the following databases for relevant trials. </p> <p> <ol id="CD012041-list-0004"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 4, April) in the Cochrane Library. </p> </li> <li> <p>MEDLINE (OVID SP; 1966 to April week 3 2018).</p> </li> <li> <p>Embase (OVID SP; 1988 to April week 3 2018).</p> </li> </ol> </p> <p>We developed a subject‐specific search strategy for MEDLINE and used that as the basis for the search strategies used in other databases listed. When appropriate, we expanded the search strategy with search terms for identifying RCTs. All search strategies can be found in <a href="./appendices#CD012041-sec-0108">Appendix 1,</a><a href="./appendices#CD012041-sec-0109">Appendix 2,</a><a href="./appendices#CD012041-sec-0110">Appendix 3,</a> and <a href="./appendices#CD012041-sec-0111">Appendix 4</a>. </p> <p>We scanned the following trial registries for ongoing and unpublished trials (April 2018). </p> <p> <ol id="CD012041-list-0005"> <li> <p>World Health Organization International Clinical Trials Resgistry Platform (WHO ICTRP).</p> </li> <li> <p>ClinicalTrials.gov.</p> </li> </ol> </p> </section> <section id="CD012041-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We scanned the reference lists and citations of included trials and any relevant systematic reviews identified for further references to additional trials. We manually searched for relevant citations from published studies, previous systematic reviews, and conference proceedings from major intensive care and nutrition societies (i.e. Intensive Care Society, UK; European Society of Intensive Care Medicine; Society of Critical Care Medicine; American Thoracic Society; Canadian Critical Care Society; American Society of Parenteral and Enteral Nutrition; European Society for Parenteral and Enteral Nutrition). </p> <p>When necessary, we contacted trial authors to request additional information.</p> </section> </section> <section id="CD012041-sec-0047"> <h3 class="title" id="CD012041-sec-0047">Data collection and analysis</h3> <section id="CD012041-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (AD and RC) independently screened appropriate studies for study characteristics and outcomes. We resolved disagreements by further discussion and with involvement of a third review author (MG). </p> </section> <section id="CD012041-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AD and RC/VL) independently performed data extraction using a data extraction form that was piloted before it was applied in this study (<a href="./appendices#CD012041-sec-0112">Appendix 5</a>). We recorded study characteristics including patient population (ARDS), intervention details (type, dose, duration), study methods (blinding, allocation, etc.), and outcome measures of interest. We resolved disagreements by consensus or by consultation with the third member of the review author team (MG). </p> <p>If observations were not reported as means and standard deviations (SDs), we contacted trial authors for additional information. In the absence of any further information, we used the statistical equation from <a href="./references#CD012041-bbs2-0029" title="HozoPS , DjulbegovicB , HozoI . Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology2005;5:13. [PUBMED: 15840177] ">Hozo 2005</a> to convert the median (range/interquartile range (IQR)) to the mean (SD). We estimated the SD as IQR/1.35, standard error of the mean (SEM) × √(n), 95% confidence interval (CI)/1.96. We estimated standard deviations from P values according to information provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012041-bbs2-0028" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD012041-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AD and RC/VL) assessed the risk of bias of included studies according to criteria presented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005000.pub2/full#CD005000-bbs2-0037" target="_blank">Higgins 2011</a>). We resolved disagreements by discussion or by consultation with the third review author (MG). We assigned the included studies to low risk of bias (when all domains were satisfied), high risk of bias (if one or more domains were inadequate), or unclear risk of bias, according to the criteria provided in the Cochrane 'Risk of bias' tool. We used the following six domains to assess risk of bias in the included studies. </p> <p> <ol id="CD012041-list-0006"> <li> <p>Selection bias (random sequence generation and allocation concealment).</p> </li> <li> <p>Performance bias (blinding of participants and personnel).</p> </li> <li> <p>Detection bias (blinding of outcome assessment).</p> </li> <li> <p>Attrition bias (incomplete outcome data).</p> </li> <li> <p>Reporting bias (selective reporting).</p> </li> <li> <p>Any other potential biases that might be present.</p> </li> </ol> </p> </section> <section id="CD012041-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We based the outcome analysis on intention‐to‐treat (ITT). We calculated weighted treatment effects using Review Manager 5.3 (<a href="./references#CD012041-bbs2-0044" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). We expressed dichotomous outcomes, such as mortality, as risk ratios (RRs) with 95% confidence intervals (CIs), and continuous variables as mean differences (MDs) with standard deviations (SDs). </p> </section> <section id="CD012041-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>To prevent unit of analysis issues, when combining groups for continuous outcomes, we used the formula suggested by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012041-bbs2-0028" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD012041-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>When we encountered missing data, we contacted the authors of included studies to request further information. In the absence of an appropriate response, we analysed the data using the best available information. We performed ITT analysis. </p> </section> <section id="CD012041-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the clinical heterogeneity of studies in relation to study population, interventions, and outcome measures. We also assessed inconsistencies and variability in outcomes among studies using the I² statistic. Variation greater than 40% among outcomes may not be explained by sampling variation. We assumed substantial statistical heterogeneity when the I² statistic exceeded 40% (<a href="./references#CD012041-bbs2-0028" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD012041-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We included 10 studies; therefore, we used graphical evidence of reporting biases via contour‐enhanced funnel plots with a subsequent Harbord or Egger's test (<a href="./references#CD012041-bbs2-0019" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>; <a href="./references#CD012041-bbs2-0023" title="HarbordRM , EggerM , SterneJA . A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine2006;25(20):3443‐57. [PUBMED: 16345038] ">Harbord 2006</a>). </p> </section> <section id="CD012041-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We pooled data according to the type of immunomodulatory agent. Most studies used a combination of omega‐3 fatty acid, GLA, and antioxidant solutions; therefore, we pooled the results of these studies. We conducted statistical data analysis using Review Manager 5.3 (<a href="./references#CD012041-bbs2-0044" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>), in accordance with recommendations provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012041-bbs2-0028" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We based our analysis on the ITT principle and utilized fixed‐effect and random‐effects models, depending on statistical heterogeneity. We used a fixed‐effect model unless we noted significant statistical heterogeneity, defined by an I² value &gt; 40%. </p> </section> <section id="CD012041-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We conducted subgroup analyses for the primary outcome according to the following.</p> <p> <ol id="CD012041-list-0007"> <li> <p>Type of intervention.</p> </li> <li> <p>Route of intervention (parenteral/enteral).</p> </li> <li> <p>Mode of intervention (continuous/bolus).</p> </li> <li> <p>Intervention duration (days).</p> </li> </ol> </p> </section> <section id="CD012041-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We performed sensitivity analysis for the primary outcome while excluding studies with high risk of bias. Continuous data for the secondary outcomes were skewed. We conducted sensitivity analysis for these secondary outcomes by log transformation. Given that we obtained no raw log‐transformed data from study authors, we transformed the mean and the standard deviation in accordance with recommendations provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012041-bbs2-0028" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). Analyses for two of the secondary outcomes ‐ ICU‐free days and ventilator‐free days at day 28 ‐ were sensitive to statistical methods; we also performed sensitivity analyses for these outcomes using both fixed‐effect and random‐effects models (<a href="#CD012041-tbl-0002">Table 1</a>). </p> <div class="table" id="CD012041-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analysis for the outcomes ICU‐free days and ventilator‐free days at day 28 according to statistical methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD (95% CI), P value</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ICU‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, random‐effects, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.44 (‐1.17 to 8.06), P = 0.14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ICU‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, fixed‐effect, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.95 (0.42 to 3.48), P = 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ventilator‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, random‐effects, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.15 (‐0.91 to 5.22), P = 0.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ventilator‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, fixed‐effect, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.06 to 1.94), P = 0.04</p> </td> </tr> </tbody> </table> </div> <section id="CD012041-sec-0059"> <h5 class="title">'Summary of findings' table and GRADE</h5> <p>We used the principles of the GRADE system to assess the quality of the body of evidence associated with specific outcomes (<a href="./references#CD012041-bbs2-0022" title="GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchunemannHJ . What is 'quality of evidence' and why is it important to clinicians. BMJ2008;336:995‐8. [MEDLINE: 18456631] ">Guyatt 2008</a>): all‐cause mortality, ICU length of stay, ventilator days, PaO₂/FiO₂ ratio at day 4, and adverse events. We constructed a 'Summary of findings' table using GRADE software (<a href="./references#CD012041-bbs2-0021" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 6 August 2016. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT</a>). Through the GRADE approach, we appraised the quality of a body of evidence based on the extent to which one can be confident that an estimate of effect or association reflects the item being assessed. Assessment of the quality of a body of evidence considers within‐study risk of bias (methodological quality), directness of evidence, heterogeneity of data, precision of effect estimates, and risk of publication bias. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012041-sec-0060" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012041-sec-0060"></div> <section id="CD012041-sec-0061"> <h3 class="title">Description of studies</h3> <p>See characteristics of <a href="#CD012041-sec-0063">Included studies</a>. </p> <section id="CD012041-sec-0062"> <h4 class="title">Results of the search</h4> <p>The combined search yielded 3367 studies for possible inclusion. We chose 131 abstracts for further evaluation after screening and removal of duplicates. We retrieved a total of 13 publications reporting 10 RCTs (<a href="#CD012041-fig-0001">Figure 1</a>). We included the publication that reported the main clinical outcomes, and we omitted duplicate reports. </p> <div class="figure" id="CD012041-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012041-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012041-sec-0063"> <h4 class="title">Included studies</h4> <section id="CD012041-sec-0064"> <h5 class="title">Characteristics of patient population</h5> <p>Nine of the 10 included studies used the American‐European Consensus Criteria (AECC) for identification of ARDS or ALI (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). The remaining study enrolled ventilated patients with septic shock and did not explicitly define this population as ARDS/ALI or not (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>). However, baseline characteristics suggest that the PaO₂/FiO₂ ratio was &lt; 300 mmHg for all participants, and of those, 71% had ARDS at the time of recruitment. It is possible that not all of these participants may have satisfied ARDS/ALI criteria. For included studies, the mean PaO₂/FiO₂ was 157 mmHg for intervention groups and 167 mmHg for control groups, suggesting moderate severity according to the current Berlin definition of ARDS (<a href="./references#CD012041-bbs2-0043" title="ARDS Definition Task Force, RanieriVM , RubenfeldGD , ThompsonBT , FergusonND , CaldwellE , FanE , et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA2012;307(23):2526‐33. [PUBMED: 22797452] ">Ranieri 2012</a>). Three studies were conducted specifically in participants with sepsis‐induced ARDS (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). </p> </section> <section id="CD012041-sec-0065"> <h5 class="title">Characteristics of intervention provided</h5> <p>We did not identify any other intervention apart from omega‐3 fatty acids (EPA and DHA) and GLA with or without antioxidant‐based enteral formula or supplementation. Several clinical trials investigated the use of glutamine supplementation for critical illness, but none specifically focused on ARDS (<a href="./references#CD012041-bbs2-0048" title="vanZantenAR , DhaliwalR , GarrelD , HeylandDK . Enteral glutamine supplementation in critically ill patients: a systematic review and meta‐analysis. Critical Care2015;19:294. [PUBMED: 26283217] ">van Zanten 2015</a>). </p> <p>Among the 10 included studies, six studies used a similar enteral preparation (Oxepa; Abbott Nutrition/Abbott Laboratories, Columbus, OH, USA) continuously supplemented with EPA, DHA, GLA, and antioxidants (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). Four of these six studies used an isocaloric high‐fat formulation (Pulmocare; Abborr Nutrition/Abbott Laboratories, Columbus, OH, USA) for control groups (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). The remaining two studies used a carbohydrate‐based control formulation (Ensure Plus or Ensure Liquid; Abbott Laboratories, East Windsor, NJ, USA) (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). </p> <p>Three studies used additional enteral supplementation of fish oil (<a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), omega‐3 gels (<a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>), or intravenous formulation with 10% fish oil (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>), and control groups received the same enteral feeding formulation as intervention groups. One study gave boluses of a high‐fat formulation enriched in EPA, DHA, GLA, and antioxidants and compared this with isocaloric‐isovolaemic carbohydrate‐rich control nutrition (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>). </p> <p>Five studies defined a target enteral nutrition delivery rate of 50% to 75% of basal/resting energy expenditure (BEE/REE) for the first 24 hours with variable increments to achieve 70% to 100% of BEE/REE (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). The duration of intervention was 7 or fewer days (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>), 14 days (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), 21 days (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>), or 28 days (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>). </p> </section> <section id="CD012041-sec-0066"> <h5 class="title">Outcome measures reported</h5> <p>All 10 included studies reported mortality. One study reported this for the duration of the study period (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>), six studies at 28 days (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>), and one study at hospital discharge or at day 60 (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>). One study reported in‐hospital mortality and mortality at 60 days (<a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), and another at only 60 days (<a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). </p> <p>Eight studies reported ICU LOS (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), and five reported ICU‐free days at day 28 (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Three studies reported hospital LOS (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). </p> <p>Seven studies reported ventilator days (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), and six reported this outcome as ventilator‐free days at day 28 (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). </p> <p>All included studies reported changes in oxygenation index (PaO₂/FiO₂ ratio) for various time points (baseline, day 1, day 2, day 3, day 4, day 5, day 7, day 8, day 14, and day 21). Six studies reported day 4 PaO₂/FiO₂ ratios (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), and seven studies reported day 7 PaO₂/FiO₂ ratios (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). We used these time points for the meta‐analysis. </p> <p>Researchers reported new organ failure in several different ways: change in or worst MODS (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), change in SOFA score (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>), number of participants with new organ failure (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>), and organ failure‐free days (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>). </p> <p>Three studies reported nosocomial infection (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). </p> <p>Six studies reported adverse events (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Two studies reported system‐based adverse events with total numbers of events (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>). One study reported individual and total numbers of adverse events (<a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). </p> <p>See <a href="./references#CD012041-sec-0120" title="">Characteristics of included studies</a>. </p> </section> </section> <section id="CD012041-sec-0067"> <h4 class="title">Excluded studies</h4> <p>We excluded no randomized controlled studies.</p> <section id="CD012041-sec-0068"> <h5 class="title">Awaiting classification</h5> <p>No studies are currently awaiting classification.</p> </section> <section id="CD012041-sec-0069"> <h5 class="title">Ongoing studies</h5> <p>We identified no ongoing studies.</p> </section> </section> </section> <section id="CD012041-sec-0070"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD012041-fig-0002">Figure 2</a> and <a href="#CD012041-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD012041-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012041-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012041-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012041-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012041-sec-0071"> <h4 class="title">Allocation</h4> <p>All included studies reported randomization. EIght studies reported the method of random sequence generation used (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). One study described alternating allocation (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>), and two other studies did not describe the method of randomization used (<a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). We categorized these studies as having high risk of selection bias. Five studies did not specifically report on allocation concealment, and we categorized these as having unclear risk of bias (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). </p> </section> <section id="CD012041-sec-0072"> <h4 class="title">Blinding</h4> <p>Six studies were double‐blinded (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). One study was not blinded (<a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). Three other studies reported single or investigator blinding (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). We assigned these studies as having high risk of performance or detection bias (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). </p> </section> <section id="CD012041-sec-0073"> <h4 class="title">Incomplete outcome data</h4> <p>We detected attrition bias in five studies that excluded participants from their ITT analysis for various reasons, including diarrhoea, steroid use, withdrawal of care, or treating physician preference, and as a consequence of protocol violations (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). </p> </section> <section id="CD012041-sec-0074"> <h4 class="title">Selective reporting</h4> <p>We judged that all 10 included studies had low risk of reporting bias, and they reported all prespecified outcomes. </p> </section> <section id="CD012041-sec-0075"> <h4 class="title">Other potential sources of bias</h4> <p>Authors of four studies reported that they were industry supported (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). We rated these studies as having unclear risk of bias. </p> </section> </section> <section id="CD012041-sec-0076"> <h3 class="title" id="CD012041-sec-0076">Effects of interventions</h3> <p>See: <a href="./full#CD012041-tbl-0001"><b>Summary of findings for the main comparison</b> Omega‐3 fatty acids and antioxidants compared with placebo or standard nutrition for acute respiratory distress syndrome (ARDS)</a> </p> <section id="CD012041-sec-0077"> <h4 class="title">Comparison. Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition</h4> <section id="CD012041-sec-0078"> <h5 class="title">Primary outcome: all‐cause mortality (longest period reported)</h5> <p>All studies reported mortality. The range of reported mortality varied between studies: six studies reported this outcome at day 28 (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>), three studies at day 60 (<a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>), and one for the study duration. We included all 10 studies with 1015 participants in this analysis (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). No evidence showed the use of omega‐3 fatty acids and antioxidants for reducing mortality at the longest period reported (risk ratio (RR) 0.79, 95% confidence interval (CI) 0.59 to 1.07; I² = 42%; participants = 1015; <a href="./references#CD012041-fig-0005" title="">Analysis 1.1</a>). The pooled control group mortality rate was 28%, and the pooled intervention group mortality rate was 23.5% for the longest period reported. Overall mortality varied between studies and ranged from 6% to 43%. A funnel plot of the primary outcome prepared to test the effect of publication bias showed no evidence of data asymmetry (Egger's regression test, with P = 0.81) (<a href="#CD012041-fig-0004">Figure 4</a>). We downgraded the quality of evidence by two levels due to inconsistency from clinical and methodological heterogeneity and indirectness for intervention and comparator. </p> <div class="figure" id="CD012041-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, outcome: 1.1 All‐cause mortality (longest period reported)." data-id="CD012041-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, outcome: 1.1 All‐cause mortality (longest period reported). </p> </div> </div> </div> </section> <section id="CD012041-sec-0079"> <h5 class="title">Secondary outcomes</h5> <section id="CD012041-sec-0080"> <h6 class="title">Mortality at 28 days</h6> <p>Six studies with 466 participants reported 28‐day mortality (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). We noted uncertain evidence for use of omega‐3 fatty acids and antioxidants in terms of mortality at 28 days (RR 0.64, 95% CI 0.49 to 0.84; I² = 0%; <a href="./references#CD012041-fig-0006" title="">Analysis 1.2</a>). This analysis was limited by the small number of participants, which accounted for less than 50% of the total participants included. We downgraded the quality of evidence by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for both intervention and comparator. </p> </section> <section id="CD012041-sec-0081"> <h6 class="title">Intensive care unit length of stay (ICU LOS) and ICU‐free days at day 28</h6> <p>Eight studies with 639 participants reported ICU LOS (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Two studies reported this outcome as mean ± standard error (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). Two studies published separate data for participants who survived and those who did not survive (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). We combined these groups according to recommendations provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012041-bbs2-0028" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We obtained further information from the authors of three studies (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). We found uncertain evidence suggesting that omega‐3 fatty acids and antioxidants may reduce ICU LOS (mean difference (MD) ‐3.09 days, 95% CI ‐5.19 to ‐0.99; I² = 55%; <a href="./references#CD012041-fig-0007" title="">Analysis 1.3</a>). </p> <p>Five studies with 607 participants reported ICU‐free days at day 28 (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). For two studies, we estimated the standard deviation from the P value or the IQR (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>), respectively, as we were not able to obtain further information from study authors. We found uncertain evidence that omega‐3 fatty acids and antioxidants may increase ICU‐free days at day 28 (MD 3.44, 95% CI ‐1.17 to 8.06; I² = 87%; <a href="./references#CD012041-fig-0008" title="">Analysis 1.4</a>). We performed random‐effects model analysis due to significant statistical heterogeneity, with I² = 87%. </p> <p>We downgraded the quality of evidence for both of these outcomes by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> <section id="CD012041-sec-0082"> <h6 class="title">Ventilator days and ventilator‐free days at day 28</h6> <p>Seven studies with 581 participants reported duration of mechanical ventilation (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Uncertain evidence suggests that omega‐3 fatty acids and antioxidants may reduce the duration of mechanical ventilation (MD ‐2.24, 95% CI ‐3.77 to ‐0.71; I² = 7%; <a href="./references#CD012041-fig-0009" title="">Analysis 1.5</a>). Six studies with 665 participants reported the duration of mechanical ventilation as ventilation‐free days at day 28 (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Uncertain evidence suggests that omega‐3 fatty acids and antioxidants may increase ventilation‐free days (MD 2.15, 95% CI ‐0.91 to 5.22; I² = 84%; <a href="./references#CD012041-fig-0010" title="">Analysis 1.6</a>). We performed random‐effects model analysis due to significant statistical heterogeneity, with I² = 84%. </p> <p>We downgraded the quality of evidence for both of these outcomes by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> <section id="CD012041-sec-0083"> <h6 class="title">Hospital length of stay (days)</h6> <p>Three studies with 291 participants reported hospital length of stay (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Uncertain evidence suggests that omega‐3 fatty acids and antioxidants may reduce the duration of hospital LOS (MD ‐2.79, 95% CI ‐7.01 to 1.44; I² = 0%; <a href="./references#CD012041-fig-0011" title="">Analysis 1.7</a>). We downgraded the quality of evidence by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> <section id="CD012041-sec-0084"> <h6 class="title">Indices of oxygenation (measured as PaO₂/FiO₂ ratio (mmHg) at day 4 and day 7)</h6> <p>Researchers commonly reported oxygenation as the PaO₂/FiO₂ ratio (mmHg). Nine studies reported this outcome at day 4 (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Two of these studies presented their PaO₂/FiO₂ data in pictorial format (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). We were able to obtain additional information from one study (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>). We estimated the SD from P values for two studies (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>). However, we were not able to include one study due to lack of further information (<a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). Uncertain evidence suggests that omega‐3 fatty acids and antioxidants may improve oxygenation defined as the PaO₂/FiO₂ ratio at day 4 (eight studies with 676 participants) (MD 39 mmHg, 95% Cl 11 to 67 mmHg; I² = 68%; <a href="./references#CD012041-fig-0012" title="">Analysis 1.8</a>). Nine studies with 465 participants reported the PaO₂/FiO₂ ratio at day 7 (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Uncertain evidence suggests that omega‐3 fatty acids and antioxidants may improve oxygenation defined as PaO₂/FiO₂ ratios at day 7 (MD 23 mmHg, 95% Cl 2 to 45 mmHg; I² = 54%; <a href="./references#CD012041-fig-0013" title="">Analysis 1.9</a>). We downgraded the quality of evidence for both of these outcomes by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> <section id="CD012041-sec-0085"> <h6 class="title">Other organ failure (measured as change in organ failure scores: SOFA score, MODS, and number of participants with new organ failure) </h6> <p>Seven studies reported new organ failure in several different ways (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Only two studies (249 participants) reported the number of participants with new organ failure (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>), and we pooled results of these studies. Use of omega‐3 fatty acids and antioxidants for prevention of new organ failure is uncertain (RR 0.45, 95% CI 0.32 to 0.63; I² = 0%; <a href="./references#CD012041-fig-0014" title="">Analysis 1.10</a>). We downgraded the quality of evidence by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. We were not able to pool other studies due to variation in reporting this outcome as MODS (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>), worse MODS (<a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), SOFA score (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>), organ failure‐free days (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>), and changes in SOFA scoring (<a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). </p> </section> <section id="CD012041-sec-0086"> <h6 class="title">Nosocomial infection (additional infection developed during hospital stay)</h6> <p>Three studies with 450 participants reported the number of participants with new nosocomial infection (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). Uncertain evidence suggests that omega‐3 fatty acids and antioxidants may reduce new nosocomial infection between groups (RR 1.01, 95% CI 0.76 to 1.33; I² = 0%; <a href="./references#CD012041-fig-0015" title="">Analysis 1.11</a>). We downgraded the quality of evidence by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> <section id="CD012041-sec-0087"> <h6 class="title">Adverse events (cardiac events, gastrointestinal events, and total adverse events)</h6> <p>Six studies reported adverse events (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Two studies reported these as system based (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>), and <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a> reported all adverse events. Three studies with 339 participants reported cardiac adverse events (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Uncertain evidence suggests that use of omega‐3 fatty acids and antioxidants may increase cardiac events (RR 0.87, 95% CI 0.09 to 8.46; I² = 57%; <a href="./references#CD012041-fig-0016" title="">Analysis 1.12</a>). Five studies reported gastrointestinal adverse events (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>). One study reported these as a percentage of ventilated days, and we did not include this value in the meta‐analysis (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>). Uncertain evidence suggests that use of omega‐3 fatty acids and antioxidants may increase gastrointestinal events (four studies with 427 participants) (RR 1.11, 95% CI 0.71 to 1.75; I² = 0%; <a href="./references#CD012041-fig-0017" title="">Analysis 1.13</a>). Five studies with 517 participants reported total numbers of adverse events (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). Uncertain evidence suggests that use of omega‐3 fatty acids and antioxidants may increase total numbers of adverse events between groups (RR 0.91, 95% CI 0.67 to 1.23; I² = 0%; <a href="./references#CD012041-fig-0018" title="">Analysis 1.14</a>). We downgraded the quality of evidence for all these outcomes by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> </section> <section id="CD012041-sec-0088"> <h5 class="title">Subgroup analysis for the primary outcome: all‐cause mortality (longest period reported)</h5> <section id="CD012041-sec-0089"> <h6 class="title">Type of intervention</h6> <p>The type of intervention varied between studies, as explained previously in the <a href="#CD012041-sec-0061">Description of studies</a> section. For the primary outcome, we performed a subgroup analysis for types of intervention given. Four studies with 361 participants added an enteral formula enriched in EPA, GLA, DHA, and antioxidants to a lipid‐rich omega‐6 fatty acid‐based control diet (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). We are uncertain of any mortality benefit when investigators compared an omega‐3 fatty acid and/or antioxidant group versus a lipid‐rich control group (RR 0.57, 95% CI 0.42 to 0.78; I² = 0%; <a href="./references#CD012041-fig-0019" title="">Analysis 1.15</a>), or versus a carbohydrate‐rich control group (RR 1.13, 95% CI 0.57 to 2.22; I² = 0%; participants = 178; studies = 2; <a href="./references#CD012041-fig-0019" title="">Analysis 1.15</a>) (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>), or versus additional supplementation of omega‐3 fatty acids (RR 0.75, 95% CI 0.48 to 1.15; I² = 0%; participants = 204; studies = 3; <a href="./references#CD012041-fig-0019" title="">Analysis 1.15</a>) (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). </p> </section> <section id="CD012041-sec-0090"> <h6 class="title">Route of administration (parenteral/enteral) of intervention</h6> <p>Only one study gave intravenous omega‐3 fatty acid supplementation (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>). All remaining studies gave enteral supplementation. We are uncertain of any mortality benefit derived by route of administration of the intervention (nine studies with 954 participants) (RR 0.82, 95% CI 0.59 to 1.14; I² = 47%; <a href="./references#CD012041-fig-0020" title="">Analysis 1.16</a>) (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). </p> </section> <section id="CD012041-sec-0091"> <h6 class="title">Mode (continuous/bolus) of intervention</h6> <p>Six studies gave continuous enteral nutrition (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>; <a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>), and one study used intravenous infusion (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>). The remaining three studies used bolus supplementation (<a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). We are uncertain of any mortality benefit derived by continuous infusion, received enterally or parenterally (RR 0.64, 95% CI 0.49 to 0.83; I² = 0%; participants = 600; studies = 7; <a href="./references#CD012041-fig-0021" title="">Analysis 1.17</a>). We are uncertain of any mortality benefit derived by bolus supplementation (RR 1.17, 95% CI 0.72 to 1.88; I² = 34%; participants = 415; studies = 3; <a href="./references#CD012041-fig-0021" title="">Analysis 1.17</a>). </p> </section> <section id="CD012041-sec-0092"> <h6 class="title">Duration of intervention</h6> <p>Duration of intervention varied among studies. One study reported the intervention period as 4 or fewer days (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>). Others reported 7 days (<a href="./references#CD012041-bbs2-0001" title="ElaminEM , MillerAC , ZiadS . Immune enteral nutrition can improve outcomes in medical‐surgical patients with ARDS: a prospective randomized controlled trial. Journal of Nutritional Disorders and Therapy2012;2:109. [PUBMED: 24761313] ">Elamin 2012</a>), 14 days (<a href="./references#CD012041-bbs2-0004" title="GuptaA , GovilD , BhatnagarS , GuptaS , GoyalJ , PatelS , et al. Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian Journal of Critical Care Medicine2011;15(2):108‐13. [PUBMED: 21814375 ] ">Gupta 2012</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0008" title="ShiraiK , YoshidaS , MatsumaruN , ToyodaI , OguraS . Effect of enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in patients with sepsis‐induced acute respiratory distress syndrome. Journal of Intensive Care2015;3:24. [PUBMED: 26015869] ">Shirai 2015</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>), 21 days (<a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>), and 28 days (<a href="./references#CD012041-bbs2-0003" title="Grau‐CarmonaT , Morán‐GarcíaV , García‐de‐LorenzoA , Heras‐de‐la‐CalleG , Quesada‐BellverB , López‐MartínezJ , et al. Effect of an enteral diet enriched with eicosapentaenoic acid, gamma‐linolenic acid and anti‐oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clinical Nutrition2011;30(5):578‐84. [PUBMED: 21474219] ">Grau‐Camona 2011</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>). We are uncertain of any mortality benefit associated with duration of intervention for fewer than 7 days (RR 0.61, 95% CI 0.32 to 1.17; I² = 0%; participants = 163; studies = 2; <a href="./references#CD012041-fig-0022" title="">Analysis 1.18</a>), for 14 days (RR 0.64, 95% CI 0.47 to 0.89; I² = 0%; participants = 345; studies = 5; <a href="./references#CD012041-fig-0022" title="">Analysis 1.18</a>), or for 28 days (RR 0.79, 95% CI 0.44 to 1.44; I² = 44%; participants = 235; studies = 2; <a href="./references#CD012041-fig-0022" title="">Analysis 1.18</a>). </p> <p>We downgraded the quality of evidence for all subgroup analyses by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> </section> <section id="CD012041-sec-0093"> <h5 class="title">Sensitivity analysis for the primary outcome excluding studies with high risk of bias</h5> <p>We conducted sensitivity analysis for the primary outcome while excluding studies with high risk of bias. We included four studies in the analysis (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0005" title="ParishM , ValiyiF , HamishehkarH , SanaieS , Asghari JafarabadiM , GolzariSE , et al. The effect of omega‐3 fatty acids on ARDS: a randomized double‐blind study. Advanced Pharmaceutical Bulletin2014;4(Suppl 2):555‐61. [PUBMED: 25671189] ">Parish 2014</a>; <a href="./references#CD012041-bbs2-0007" title="RiceTW , WheelerAP , ThompsonBT , deBoisblancBP , SteingrubJ , RockP . Enteral omega‐3 fatty acid, gamma‐linolenic acid, and antioxidant supplementation in acute lung injury. JAMA2011;306(14):1574‐81. [PUBMED: 21976613] ">Rice 2011</a>; <a href="./references#CD012041-bbs2-0010" title="StapletonRD , MartinTR , WeissNS , CrowleyJJ , GundelSJ , NathensAB , et al. A phase II randomized placebo‐controlled trial of omega‐3 fatty acids for the treatment of acute lung injury. Critical Care Medicine2011;39(7):1655‐62. [PUBMED: 21423000] ">Stapleton 2011</a>). We found no evidence for the use of omega‐3 fatty acids and antioxidants in reducing mortality at the longest period reported (RR 0.98, 95% CI 0.60 to 1.58; I² = 51%; participants = 561; <a href="./references#CD012041-fig-0023" title="">Analysis 2.1</a>). We graded quality of evidence as low and downgraded the evidence by two levels due to inconsistency from clinical and methodological heterogeneity and indirectness for intervention and comparator. </p> </section> <section id="CD012041-sec-0094"> <h5 class="title">Sensitivity analysis for secondary outcomes with log‐transformed data</h5> <p>Most data for continuous secondary outcomes such as ICU LOS (<a href="./references#CD012041-fig-0007" title="">Analysis 1.3</a>), ICU‐free days at day 28 (<a href="./references#CD012041-fig-0008" title="">Analysis 1.4</a>), ventilator days (<a href="./references#CD012041-fig-0009" title="">Analysis 1.5</a>), ventilator‐free days at day 28 (<a href="./references#CD012041-fig-0010" title="">Analysis 1.6</a>), and hospital LOS (<a href="./references#CD012041-fig-0011" title="">Analysis 1.7</a>) were skewed. Therefore, we performed sensitivity analysis for these outcomes from log‐transformed data. We are uncertain whether this intervention confers any beneficial effect on ICU length of stay (mean log days ‐0.08, 95% CI ‐0.23 to 0.06; participants = 639; studies = 8; I² = 0%; <a href="./references#CD012041-fig-0024" title="">Analysis 2.2</a>), ICU‐free days at day 28 (mean log days 0.34, 95% CI 0.00 to 0.68; participants = 607; studies = 5; I² = 75%; <a href="./references#CD012041-fig-0025" title="">Analysis 2.3</a>), ventilator days (mean log days ‐0.08, 95% CI ‐0.24 to 0.07; participants = 581; studies = 7; I² = 0%; <a href="./references#CD012041-fig-0026" title="">Analysis 2.4</a>), ventilator‐free days at day 28 (mean log days 0.06, 95% CI ‐0.06 to 0.18; participants = 665; studies = 6; I² = 0%; <a href="./references#CD012041-fig-0027" title="">Analysis 2.5</a>), or hospital LOS (mean log days ‐0.05, 95% CI ‐0.34 to 0.24; participants = 291; studies = 3; I² = 0%; <a href="./references#CD012041-fig-0028" title="">Analysis 2.6</a>). We downgraded the quality of evidence for all these outcomes by three levels due to increased risk of bias, inconsistency due to clinical and methodological heterogeneity, and indirectness for intervention and comparator. </p> </section> <section id="CD012041-sec-0095"> <h5 class="title">Sensitivity analysis for secondary outcomes of ICU‐free days and ventilator‐free days at day 28 according to statistical method </h5> <p>We performed sensitivity analysis using both fixed‐effect and random‐effects models for secondary outcomes of ICU‐free days and ventilator‐free days at day 28. Results were sensitive to the type of analytical method used (random‐effects or fixed‐effect model) (<a href="#CD012041-tbl-0002">Table 1</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012041-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012041-sec-0096"></div> <section id="CD012041-sec-0097"> <h3 class="title" id="CD012041-sec-0097">Summary of main results</h3> <p>We identified 10 randomized controlled trials (RCTs) evaluating effects of omega‐3 fatty acids (eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), gamma‐linolenic acid (GLA), and antioxidants, supplemented or given as part of an enteral nutrition formula, for the acute respiratory distress syndrome (ARDS) population. We identified no clinical trials with any other specific immunonutrition intervention for this patient population. We found no evidence that this type of nutrition improves the primary outcome of all‐cause mortality at the longest period reported. Included studies showed clinical heterogeneity with respect to type, mode, and duration of intervention provided and type of enteral nutrition formulation received by the control group. We have performed subgroup analysis according to differing interventions in the control group. Although we noted a statistical reduction in mortality when omega‐3 fatty acids and/or antioxidants were compared with a lipid‐rich enteral formula, we are uncertain due to very low‐quality evidence whether this intervention improves mortality in the ARDS population. We also found uncertain evidence regarding reductions in duration of mechanical ventilation, intensive care unit (ICU) length of stay, improvement in oxygenation, and increased adverse events with this intervention. </p> </section> <section id="CD012041-sec-0098"> <h3 class="title" id="CD012041-sec-0098">Overall completeness and applicability of evidence</h3> <p>We performed appropriate and thorough searches of electronic databases to identify suitable studies. We applied no restrictions. We obtained additional study details from study authors when possible. Our meta‐analysis incorporated 10 clinical trials of 1015 participants investigating immune‐modifying nutrition in patients with ARDS. All studies used omega‐3 fatty acid‐based nutritional formula with or without antioxidants for the intervention. However, this approach was subject to significant clinical and statistical heterogeneity. Overall, pooled data did not support giving omega‐3 fatty acids in combination with GLA and antioxidants to improve mortality in ARDS. Although results from some subgroup analyses indicate that the mortality risk ratio (RR) was reduced when the intervention was given as a continuous enteral infusion against a lipid‐rich control formulation, the quality of evidence is very low. Also, the isocaloric high‐fat formula used in the control group diet was enriched in omega‐6 fatty acids with high content of linolenic acid and may have been harmful: in other words, the beneficial effect reported by those studies may have been due to potentially harmful effects of the lipid‐rich diet given to the control group. </p> <p>Given that mechanical ventilator days and length of ICU stay (ICU LOS) may be influenced by the death rate, critical care clinical trials more recently have widely reported ventilator and ICU‐free days as better outcome measures. In general, ventilator‐free days and ICU‐free days at day 28 are used as a surrogate for overall ICU outcomes combining mortality with duration of mechanical ventilation and ICU length of stay, respectively. Study results show a difference in the pooled statistical analysis between outcomes of ICU LOS and ICU‐free days at day 28. This was also true for ventilator days and ventilator‐free days at day 28. Reporting of either numbers of days or numbers of free days (ventilation or ICU) can be subject to bias. For this reason, we meta‐analysed both ways of reporting all available data from published trials (ventilator days/ventilator‐free days at day 28 and ICU LOS)/ICU‐free days at day 28). Alternatively, this disagreement between our secondary composite outcomes (ICU LOS/ ventilator days and ICU‐free days/ventilator‐free days at day 28) and individual endpoints could be due to inclusion and exclusion of different studies from outcome analyses, based on available outcome measures or due to lack of standardized reporting. Nevertheless, due to low‐quality evidence, we are uncertain whether use of an omega‐3‐based immune‐modulating diet in ARDS improves ventilator days or ICU length of stay. </p> </section> <section id="CD012041-sec-0099"> <h3 class="title" id="CD012041-sec-0099">Quality of the evidence</h3> <p>Some studies did not provide adequate descriptive evidence for methods of randomization and allocation concealment. One study was unblinded, and two studies did not adequately clarify blinding of outcome assessment. Significant dropouts from several studies occurred for a variety of reasons, including protocol violations and intolerance of the intervention or trial. We graded these studies as having high risk of bias. Most studies reported anticipated outcomes and all reported mortality, although they were not adequately powered to detect differences between groups. We graded the quality of evidence for the primary outcome as low and for all secondary outcomes as very low because, despite the possibility of increased risk of bias, the primary outcome analysis included more than 1000 patients with more than 250 events and was not influenced by inclusion of studies with high risk of bias, as evidenced by the sensitivity analysis omitting these studies. Analyses of continuous outcome data for most secondary outcomes yielded skewed results. We were not able to obtain the raw transformed data from study authors; therefore, we performed sensitivity analysis using logarithmic transformations for these secondary outcomes. We encountered substantial statistical heterogeneity for several secondary outcomes. Significant clinical and statistical heterogeneity led to a priori defined subgroup analyses of the primary outcomes, according to the type of intervention provided. Several included studies showed indirectness, whereby the comparator was given nutrition with highly enriched omega‐6 fatty acids, which may have increased risk of harm. One study reported significant differences in the amount of protein given per day to control (20 g) and intervention groups (4 g). Overall, we rated the quality of evidence as low to very low because of increased risk of bias, skewed data, inconsistency, and indirectness. Further research on this topic is essential both to address the overall objective of this review and to focus on specific questions. Future RCTs should consider standardized reporting of ICU outcomes to facilitate the combination and comparison of data between studies. </p> </section> <section id="CD012041-sec-0100"> <h3 class="title" id="CD012041-sec-0100">Potential biases in the review process</h3> <p>To our knowledge, we have identified and included all published studies on this topic. Lack of standardization in reporting outcomes resulted in some studies reporting duration of ICU stay as ICU LOS and others as ICU‐free days at day 28. We encountered similar issues when dealing with duration of mechanical ventilation. This resulted in pooling of these studies separately, which was not planned when the protocol was drafted. Lack of standardized statistical data from the included studies led to assumptions of normal distribution and calculations of standard deviation from standard error, interquartile ratio (IQR), and P value, which may have introduced additional bias. </p> </section> <section id="CD012041-sec-0101"> <h3 class="title" id="CD012041-sec-0101">Agreements and disagreements with other studies or reviews</h3> <p><a href="./references#CD012041-bbs2-0041" title="Pontes‐ArrudaA , DemicheleS , SethA , SingerP . The use of an inflammation‐modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta‐analysis of outcome data. Journal of Parenteral and Enteral Nutrition2008;32(6):596‐605. [PUBMED: 18974237] ">Pontes‐Arruda 2008</a> conducted the first meta‐analysis on this topic. These review authors included three earlier studies and reported a survival advantage, improvement in oxygenation (days 4 and 7), and other clinical variables such as ICU‐ free days and ventilator‐free days at day 28 with immune‐enhancing diets (<a href="./references#CD012041-bbs2-0002" title="GadekJE , DeMicheleSJ , KarlstadMD , PachtER , DonahoeM , AlbertsonTE , et al. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linoleic acid, and antioxidants in patients with acute respiratory distress syndrome. Critical Care Medicine1999;27(8):1409‐20. [PUBMED: 10470743] NelsonJL , DeMicheleSJ , PachtER , WennbergAK , Enteral Nutrition in ARDS Study Group. Effect of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants on antioxidant status in patients with acute respiratory distress syndrome. Journal of Parenteral and Enteral Nutrition2003;27(2):98‐104. [PUBMED: 12665164] PachtER , DeMicheleSJ , NelsonJL , HartJ , WennbergAK , GadekJE . Enteral nutrition with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants reduces alveolar inflammatory mediators and protein influx in patients with acute respiratory distress syndrome. Critical Care Medicine2003;31(2):491‐500. [PUBMED: 12576957] ">Gadek 1999</a>; <a href="./references#CD012041-bbs2-0006" title="Pontes‐ArrudaA , AragãoAM , AlbuquerqueJD . Effects of enteral feeding with eicosapentaenoic acid, gamma‐linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Critical Care Medicine2006;34(9):2325‐33. [PUBMED: 16850002] ">Pontes‐Arruda 2006</a>; <a href="./references#CD012041-bbs2-0009" title="SingerP , TheillaM , FisherH , GibsteinL , GrozovskiE , CohenJ . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma‐linolenic acid in ventilated patients with acute lung injury. Critical Care Medicine2006;34(4):1033‐8. [PUBMED: 16484911] TheillaM , SingerP , CohenJ , DekeyserF . A diet enriched in eicosapentaenoic acid, gamma‐linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clinical Nutrition2007;26(6):752‐7. [PUBMED: 17933438] ">Singer 2006</a>). Another meta‐analysis that focused on mortality and oxygenation yielded the same conclusions (<a href="./references#CD012041-bbs2-0017" title="DeeBM , BrunoJJ , LalLS , CanadaTW . Effects of immune‐enhancing enteral nutrition on mortality and oxygenation in acute lung injury and acute respiratory distress syndrome: a meta‐analysis. Hospital Pharmacy2011;46(1):33‐40. ">Dee 2011</a>). Results from a subsequent meta‐analysis of seven studies contradicted these previous positive findings and revealed that enteral supplementation of omega‐3 fatty acids, GLA, and antioxidants provides no benefit in reducing clinical outcomes such as 28‐day mortality, ventilator‐free days, and ICU‐free days (<a href="./references#CD012041-bbs2-0051" title="ZhuD , ZhangY , LiS , GanL , FengH , NieW . Enteral omega‐3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta‐analysis and trial sequential analysis. Intensive Care Medicine2014;40(4):504‐12. [PUBMED: 24556914] ">Zhu 2014</a>). However, these results show improvement in oxygenation at days 4 and 7 with immune‐modulating diets. A more recent meta‐analysis led to similar conclusions (<a href="./references#CD012041-bbs2-0031" title="LiC , BoL , LiuW , LuX , JinF . Enteral immunomodulatory diet (omega‐3 fatty acid, γ‐linolenic acid and antioxidant supplementation) for acute lung injury and acute respiratory distress syndrome: an updated systematic review and meta‐analysis. Nutrients2015;7(7):5572‐85. [PUBMED: 26184293] ">Li 2015</a>). In this review, authors also subanalysed studies with high overall mortality and demonstrated a positive outcome with the intervention for patient groups with higher mortality, inferring potential benefit for those with severe ARDS (<a href="./references#CD012041-bbs2-0031" title="LiC , BoL , LiuW , LuX , JinF . Enteral immunomodulatory diet (omega‐3 fatty acid, γ‐linolenic acid and antioxidant supplementation) for acute lung injury and acute respiratory distress syndrome: an updated systematic review and meta‐analysis. Nutrients2015;7(7):5572‐85. [PUBMED: 26184293] ">Li 2015</a>). </p> <p>Our meta‐analysis was consistent with the conclusions of recently published reviews in finding no mortality benefit derived from immunomodulatory diets based on inclusion of omega‐3 fatty acids, GLA, and antioxidants. We noted no improvement in ventilator‐free days and ICU‐free days at day 28, and this was sensitive to analytical methods. These findings were also consistent with those revealed by a previous meta‐analysis (<a href="./references#CD012041-bbs2-0051" title="ZhuD , ZhangY , LiS , GanL , FengH , NieW . Enteral omega‐3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta‐analysis and trial sequential analysis. Intensive Care Medicine2014;40(4):504‐12. [PUBMED: 24556914] ">Zhu 2014</a>). Our findings are also consistent with guidelines of the Society of Critcal Care Medicine and the American Society for Parenteral and Enteral Nutrition for provision of nutritional support for adult critically ill patients, which do not recommend use of omega‐3 fatty acids in the ARDS population (<a href="./references#CD012041-bbs2-0035" title="McClaveSA , TaylorBE , MartindaleRG , WarrenMM , JohnsonDR , BraunschweigC , et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society of Parenteral and Enteral Nutrition (A.S.P.E.N). Journal of Parenteral and Enteral Nutrition2016;40(2):159‐211. [PUBMED: 26773077] ">McClave 2016</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012041-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012041-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012041-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012041-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, outcome: 1.1 All‐cause mortality (longest period reported)." data-id="CD012041-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, outcome: 1.1 All‐cause mortality (longest period reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 1 All‐cause mortality (longest period reported)." data-id="CD012041-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 1 All‐cause mortality (longest period reported). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 2 28‐day mortality." data-id="CD012041-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 2 28‐day mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 3 ICU LOS." data-id="CD012041-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 3 ICU LOS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 4 ICU‐free days at day 28." data-id="CD012041-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 4 ICU‐free days at day 28. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 5 Ventilator days." data-id="CD012041-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 5 Ventilator days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 6 Ventilator‐free days at day 28." data-id="CD012041-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 6 Ventilator‐free days at day 28. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 7 Hospital LOS." data-id="CD012041-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 7 Hospital LOS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 8 PaO₂/FiO₂ ratio at day 4." data-id="CD012041-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 8 PaO₂/FiO₂ ratio at day 4. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 9 PaO₂/FiO₂ ratio at day 7." data-id="CD012041-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 9 PaO₂/FiO₂ ratio at day 7. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 10 Patients with new organ failure." data-id="CD012041-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 10 Patients with new organ failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 11 Patients with nosocomial infection." data-id="CD012041-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 11 Patients with nosocomial infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 12 Adverse events ‐ cardiac." data-id="CD012041-fig-0016" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 12 Adverse events ‐ cardiac. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 13 Adverse events ‐ gastrointestinal." data-id="CD012041-fig-0017" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 13 Adverse events ‐ gastrointestinal. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 14 Total adverse events." data-id="CD012041-fig-0018" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 14 Total adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 15 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ type of intervention." data-id="CD012041-fig-0019" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 15 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ type of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 16 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ route of intervention." data-id="CD012041-fig-0020" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 16 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ route of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 17 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ mode of intervention (bolus or continuous)." data-id="CD012041-fig-0021" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 17 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ mode of intervention (bolus or continuous). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 18 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ duration of intervention." data-id="CD012041-fig-0022" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 18 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ duration of intervention. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 1 All‐cause mortality (longest period reported) excluding studies at high risk of bias." data-id="CD012041-fig-0023" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 1 All‐cause mortality (longest period reported) excluding studies at high risk of bias. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 2 ICU LOS." data-id="CD012041-fig-0024" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 2 ICU LOS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 3 ICU‐free days at day 28." data-id="CD012041-fig-0025" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 3 ICU‐free days at day 28. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 4 Ventilator days." data-id="CD012041-fig-0026" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 4 Ventilator days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 5 Ventilator‐free days at day 28." data-id="CD012041-fig-0027" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 5 Ventilator‐free days at day 28. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012041-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/urn:x-wiley:14651858:media:CD012041:CD012041-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_t/tCD012041-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 6 Hospital LOS." data-id="CD012041-fig-0028" src="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition, Outcome 6 Hospital LOS. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/media/CDSR/CD012041/image_n/nCD012041-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012041-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Omega‐3 fatty acids and antioxidants compared with placebo or standard nutrition for acute respiratory distress syndrome (ARDS)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Omega‐3 fatty acids and antioxidants compared with placebo or standard nutrition for acute respiratory distress syndrome (ARDS)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Patient or population:</b> adults (aged 18 years or older), mechanically ventilated participants with ARDS as defined by the Berlin definition of ARDS or, for older studies, the American‐European Consensus Criteria for both ARDS and acute lung injury </p> <p><b>Settings:</b> intensive care units in USA, Brazil, India, Iran, Israel, Japan, and Spain </p> <p><b>Intervention:</b> omega‐3 fatty acids and antioxidants </p> <p><b>Comparison:</b> placebo or standard nutrition </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo or standard nutrition</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with omega‐3 fatty acids and antioxidants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All‐cause mortality</p> <p>(longest period reported)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>280 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>221 per 1000<br/> (165 to 299) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.79</p> <p>(0.59 to 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1015</p> <p>(10 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> low<sup>a,b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ICU LOS</p> <p>(days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean 18.09 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 3.09 days lower</p> <p>(5.19 lower to 0.99 lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>639</p> <p>(8 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ventilator days</p> <p>(days)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean 12.95 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 2.24 days lower</p> <p>(3.77 days lower to 0.71 days lower)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>581</p> <p>(7 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Indices of oxygenation</p> <p>(measured as PaO₂/FiO₂ ratio at day 4)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean 180.10 mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>MD 39 mmHg higher</p> <p>(10.75 mmHg higher to 67.02 mmHg higher)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>659</p> <p>(7 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Cardiac adverse events</p> <p>(study author reported anytime during study period)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>40 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>35 per 1000<br/> (4 to 342) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.87</p> <p>(0.09 to 8.46)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>339</p> <p>(3 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gastrointestinal adverse events</p> <p>(study author reported anytime during study period)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>138 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>153 per 1000<br/> (98 to 241) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 1.11</p> <p>(0.71 to 1.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>427</p> <p>(4 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total number of adverse events</p> <p>(study author reported anytime during study period)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>243 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>222 per 1000</p> <p>(163 to 299)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.91</p> <p>(0.67 to 1.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>517</p> <p>(5 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊝⊝⊝<br/> very low<sup>a,b,c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> ARDS: acute respiratory distress syndrome; CI: confidence interval; FiO₂: fraction of inspired oxygen; ICU: intensive care unit; LOS: length of stay; MD: mean difference; PaO₂: partial pressure of arterial oxygen; RCT: randomized controlled trial; RR: risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>a</sup>Risk of bias downgraded (‐1) due to selection, performance, and attrition bias in the included studies. </p> <p><sup>b</sup>Inconsistency downgraded (‐1) due to both clinical and methodological inconsistency in the included studies. </p> <p><sup>c</sup>Indirectness downgraded (‐1) due to indirect intervention and comparator in the included studies. In some included studies, control participants' nutritional formula may have increased the risk of harm. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Omega‐3 fatty acids and antioxidants compared with placebo or standard nutrition for acute respiratory distress syndrome (ARDS)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012041-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analysis for the outcomes ICU‐free days and ventilator‐free days at day 28 according to statistical methods</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcome</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Statistical analysis</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>MD (95% CI), P value</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ICU‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, random‐effects, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.44 (‐1.17 to 8.06), P = 0.14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ICU‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, fixed‐effect, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.95 (0.42 to 3.48), P = 0.01</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ventilator‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, random‐effects, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.15 (‐0.91 to 5.22), P = 0.17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ventilator‐free days at day 28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference (IV, fixed‐effect, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.06 to 1.94), P = 0.04</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Sensitivity analysis for the outcomes ICU‐free days and ventilator‐free days at day 28 according to statistical methods</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/full#CD012041-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012041-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality (longest period reported) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.59, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 28‐day mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>466</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.49, 0.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 ICU LOS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>639</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.09 [‐5.19, ‐0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 ICU‐free days at day 28 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>607</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.44 [‐1.17, 8.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Ventilator days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.24 [‐3.77, ‐0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Ventilator‐free days at day 28 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>665</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.15 [‐0.91, 5.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Hospital LOS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.79 [‐7.01, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 PaO₂/FiO₂ ratio at day 4 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>676</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>38.88 [10.75, 67.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 PaO₂/FiO₂ ratio at day 7 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>465</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>23.44 [1.73, 45.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Patients with new organ failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.32, 0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Patients with nosocomial infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Adverse events ‐ cardiac <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>339</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.09, 8.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Adverse events ‐ gastrointestinal <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>427</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.71, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Total adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>517</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.67, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ type of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.59, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 Immunonutrition formula compared with lipid‐based control diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.42, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 Immunonutrition formula compared with carbohydrate‐based control diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.57, 2.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 Immunonutrition supplemented to same intervention and control diet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.48, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.4 Immunonutrition supplemented to different intervention and control formula</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.01, 2.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ route of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.59, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 Enteral</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>954</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.59, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 Intravenous</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.32, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ mode of intervention (bolus or continuous) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.59, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 Continuous infusion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.49, 0.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 Bolus supplementation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.72, 1.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Subgroup analysis for the primary outcome (all‐cause mortality) ‐ duration of intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.59, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 Duration &lt; 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>163</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.32, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 Duration 14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.47, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.3 Duration 21 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [1.01, 2.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.4 Duration 28 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.44, 1.44]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Omega‐3 fatty acids and antioxidants versus placebo or standard nutrition</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012041-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 All‐cause mortality (longest period reported) excluding studies at high risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>561</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.60, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 ICU LOS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>639</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.23, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 ICU‐free days at day 28 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>607</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.00, 0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Ventilator days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>581</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.24, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Ventilator‐free days at day 28 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>665</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.06, 0.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Hospital LOS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.34, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Sensitivity analysis: omega‐3 fatty acids and antioxidants versus placebo or standard nutrition</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012041.pub2/references#CD012041-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012041.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012041-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012041-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012041-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012041-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD012041-note-0012">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD012041-note-0005">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012041-note-0004">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012041-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012041-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD012041-note-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012041-note-0002">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD012041-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012041\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012041\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012041\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012041\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012041\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UiM8QuvV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012041.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012041.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012041.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012041.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012041.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718984563"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012041.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718984567"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012041.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dddaf19b41be5',t:'MTc0MDcxODk4NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 